Beta 2-adrenoceptor agonists reverse the leukotriene C4-induced release response of macrophages

Eur J Pharmacol. 1984 Dec 15;107(1):65-70. doi: 10.1016/0014-2999(84)90092-x.

Abstract

The experiments concerned the effects of beta-adrenoceptor agonists and antagonists on the leukotriene-C4 (LTC4)-induced secretory release response from carrageenan-elicited rat peritoneal macrophages. Both the non-selective beta-adrenoceptor agonist isoprenaline and the selective beta 2-adrenoceptor agonist salbutamol reversed the LTC4-induced release response. Addition of the non-selective beta-adrenoceptor antagonist sotalol or the beta 2-selective antagonist H3525 abolished these effects. Practolol, a selective beta 1-adrenoceptor antagonist was without any effect on the isoprenaline-LTC4 interaction. These results are consistent with the presence of beta 2-adrenoceptors on macrophages. The results of this study are discussed in view of a possible, cyclic adenosine 3'5'-monophosphate (cAMP)-mediated interaction between prostaglandin E2 and LTC4 in modulating macrophage function.

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology*
  • Albuterol / pharmacology*
  • Animals
  • Drug Interactions
  • Ephedrine / analogs & derivatives*
  • Ephedrine / pharmacology
  • Glucuronidase / metabolism
  • Isoproterenol / pharmacology*
  • Lysosomes / drug effects
  • Macrophages / drug effects
  • Male
  • Peritoneum / drug effects*
  • Prostaglandins E / metabolism*
  • Rats
  • Rats, Inbred Strains
  • SRS-A / antagonists & inhibitors
  • SRS-A / pharmacology*
  • Sotalol / pharmacology*
  • Thromboxane B2 / metabolism

Substances

  • Adrenergic beta-Antagonists
  • Prostaglandins E
  • SRS-A
  • H 35-25
  • Thromboxane B2
  • Sotalol
  • Glucuronidase
  • Ephedrine
  • Isoproterenol
  • Albuterol